$MTEX

MANNATECH INC

Mannatech develops and sells proprietary nutritional supplements, skin care and anti-aging products, and weight-management and fitness products for consumers seeking health and wellness products. Its sole reporting segment operates in twenty-five markets. Products are organized into Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials categories. Brands and products include Ambrotose, TruHealth, Luminovation, and OsoLean. Mannatech principally sells through network marketing, with independent associates and preferred customers purchasing products; independent associates can participate in its compensation plan, while preferred customers cannot. In mainland China, its subsidiary Meitai sells Mannatech products through a cross-border e-commerce website for personal use, with a rewards program for customer referrals. Mannatech contracts with third parties to manufacture all its products. It is headquartered in Flower Mound, Texas.

0
0
2

No SEC Form 4 filings for $MTEX in the last 30 days.

See all $MTEX insider activity →

Mannatech Reports Financial Results for Third Quarter 2026

MANNATECH INC (MTEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mannatech Reports Financial Results for Third Quarter 2026 (Flower Mound, Texas) November 12, 2026 - Mannatech, Incorporated (NASDAQ: MTEX ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today

Mann regains Nasdaq equity compliance after Swiss holding acquisition, cites reduced Swiss withholding

Mann (MTEX) believes it has regained compliance with Nasdaq's $2.5M equity requirement after acquiring 100% ownership of its Swiss subsidiary. The Swiss tax authority ruled distributions now qualify for a reduced 5% withholding rate, altering deferred tax liabilities. Nasdaq will continue monitoring. According to the company, the changes were effective as of September 30, 2026.

MTEX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning MTEX (MANNATECH INC). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.

Recent MTEX coverage spans corporate actions, earnings and regulation.

What's driving MTEX

AlphAI scores every news story that mentions MTEX with an AI model for sentiment and relevance, and aggregates insider trades from MANNATECH INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MTEX

Score
$MTEXMedEarnings

Mannatech Reports Financial Results for Third Quarter 2026

MANNATECH INC (MTEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mannatech Reports Financial Results for Third Quarter 2026 (Flower Mound, Texas) November 12, 2026 - Mannatech, Incorporated (NASDAQ: MTEX ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today

Mann regains Nasdaq equity compliance after Swiss holding acquisition, cites reduced Swiss withholding

Mann (MTEX) believes it has regained compliance with Nasdaq's $2.5M equity requirement after acquiring 100% ownership of its Swiss subsidiary. The Swiss tax authority ruled distributions now qualify for a reduced 5% withholding rate, altering deferred tax liabilities. Nasdaq will continue monitoring. According to the company, the changes were effective as of September 30, 2026.

$MTEXMedListing notice· deficiency

Nasdaq Deficiency. On April 20, 2026, Mannatech, Incorporated received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC…

MANNATECH INC (MTEX) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. Nasdaq Deficiency. On April 20, 2026, Mannatech, Incorporated (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with the minimum stock

$MTEXMedExec change· retired

MANNATECH INC (MTEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

MANNATECH INC (MTEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Mannatech Announces Retirement of J. Stanley Fredrick from the Board and Appointment of Robert Toth as Chairman of the Board FLOWER MOUND, Texas--(BUSINESS WIRE)—September 1, 2026-- Mannatech, Incorporated (NASDAQ: MTEX ) announced the retirement of J. Stanley Fredri

$MTEXMedEarnings

Mannatech Reports Financial Results for Second Quarter 2026

MANNATECH INC (MTEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mannatech Reports Financial Results for Second Quarter 2026 (Flower Mound, Texas) August 12, 2026 - Mannatech, Incorporated (NASDAQ: MTEX ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today a

$MTEXLowExec change· appointed

MANNATECH INC (MTEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

MANNATECH INC (MTEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. mtex20260605_8k.htm false 0001056358 0001056358 2026-06-03 2026-06-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event repo

Mannatech Swings to $2.3M Profit in Q4: Cost Cuts Offset Sales Drop

Mannatech (NASDAQ: MTEX) reported a net income of $2.3 million for Q4 2024, a significant improvement from a net loss in Q4 2023, despite an 11.3% decrease in net sales to $29.0 million. The company attributed this return to profitability to strict cost management, including substantial reductions in selling and administrative expenses. For the full year 2024, Mannatech also achieved a net income of $2.5 million, compared to a loss in 2023, by mitigating the impact of declining sales and challenging economic conditions, particularly in the Asia/Pacific region.

Related tickers